vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and WESTWOOD HOLDINGS GROUP INC (WHG). Click either name above to swap in a different company.

WESTWOOD HOLDINGS GROUP INC is the larger business by last-quarter revenue ($25.0M vs $16.1M, roughly 1.6× Fortress Biotech, Inc.). WESTWOOD HOLDINGS GROUP INC runs the higher net margin — 3.1% vs -24.5%, a 27.6% gap on every dollar of revenue. On growth, WESTWOOD HOLDINGS GROUP INC posted the faster year-over-year revenue change (7.4% vs 6.3%). Over the past eight quarters, Fortress Biotech, Inc.'s revenue compounded faster (11.0% CAGR vs 4.9%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Westwood Studios, Inc. was an American video game developer based in Las Vegas, Nevada. It was founded by Brett Sperry and Louis Castle in 1985 as Brelous Software, but got changed after 2 months into Westwood Associates and was renamed to Westwood Studios when Virgin Games bought the company in 1992. The company was bought by Electronic Arts alongside Virgin Interactive's North American operations in 1998. In January 2003, it was announced that Westwood, alongside Westwood Pacific, would be ...

FBIO vs WHG — Head-to-Head

Bigger by revenue
WHG
WHG
1.6× larger
WHG
$25.0M
$16.1M
FBIO
Growing faster (revenue YoY)
WHG
WHG
+1.1% gap
WHG
7.4%
6.3%
FBIO
Higher net margin
WHG
WHG
27.6% more per $
WHG
3.1%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FBIO
FBIO
Annualised
FBIO
11.0%
4.9%
WHG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FBIO
FBIO
WHG
WHG
Revenue
$16.1M
$25.0M
Net Profit
$-3.9M
$782.0K
Gross Margin
66.1%
Operating Margin
-28.8%
Net Margin
-24.5%
3.1%
Revenue YoY
6.3%
7.4%
Net Profit YoY
41.8%
EPS (diluted)
$-0.15
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
WHG
WHG
Q1 26
$25.0M
Q4 25
$16.1M
$27.1M
Q3 25
$17.6M
$24.3M
Q2 25
$16.4M
$23.1M
Q1 25
$13.1M
$23.3M
Q4 24
$15.1M
$46.5M
Q3 24
$14.6M
$23.7M
Q2 24
$14.9M
$22.7M
Net Profit
FBIO
FBIO
WHG
WHG
Q1 26
$782.0K
Q4 25
$-3.9M
$1.8M
Q3 25
$5.8M
$3.7M
Q2 25
$15.5M
$1.0M
Q1 25
$-10.6M
$478.0K
Q4 24
$-6.8M
$3.7M
Q3 24
$-12.9M
$-1.2M
Q2 24
$-10.9M
$-378.0K
Gross Margin
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Operating Margin
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
-28.8%
8.0%
Q3 25
-38.6%
8.3%
Q2 25
-222.2%
3.8%
Q1 25
-169.9%
-0.3%
Q4 24
-158.3%
10.0%
Q3 24
-151.0%
-2.1%
Q2 24
-186.5%
-18.4%
Net Margin
FBIO
FBIO
WHG
WHG
Q1 26
3.1%
Q4 25
-24.5%
6.8%
Q3 25
33.2%
15.4%
Q2 25
94.4%
4.5%
Q1 25
-80.6%
2.1%
Q4 24
-44.7%
14.5%
Q3 24
-88.0%
-5.0%
Q2 24
-73.5%
-1.7%
EPS (diluted)
FBIO
FBIO
WHG
WHG
Q1 26
$0.09
Q4 25
$-0.15
$0.21
Q3 25
$0.11
$0.41
Q2 25
$0.45
$0.12
Q1 25
$-0.48
$0.05
Q4 24
$-0.16
$0.45
Q3 24
$-0.76
$-0.15
Q2 24
$-0.73
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
WHG
WHG
Cash + ST InvestmentsLiquidity on hand
$79.4M
$23.4M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$126.1M
Total Assets
$185.5M
$150.4M
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
WHG
WHG
Q1 26
$23.4M
Q4 25
$79.4M
$47.7M
Q3 25
$86.2M
$41.3M
Q2 25
$74.4M
$35.2M
Q1 25
$91.3M
$29.1M
Q4 24
$57.3M
$46.5M
Q3 24
$58.9M
$48.3M
Q2 24
$76.2M
$44.1M
Total Debt
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Stockholders' Equity
FBIO
FBIO
WHG
WHG
Q1 26
$126.1M
Q4 25
$49.9M
$125.6M
Q3 25
$55.9M
$123.9M
Q2 25
$43.9M
$122.4M
Q1 25
$22.3M
$121.4M
Q4 24
$22.7M
$120.3M
Q3 24
$21.2M
$120.4M
Q2 24
$17.9M
$120.5M
Total Assets
FBIO
FBIO
WHG
WHG
Q1 26
$150.4M
Q4 25
$185.5M
$162.3M
Q3 25
$181.4M
$154.0M
Q2 25
$159.9M
$146.3M
Q1 25
$178.1M
$135.0M
Q4 24
$144.2M
$150.0M
Q3 24
$127.1M
$151.5M
Q2 24
$145.7M
$147.4M
Debt / Equity
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
WHG
WHG
Operating Cash FlowLast quarter
$-12.5M
$-2.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-3.28×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
WHG
WHG
Q1 26
$-2.6M
Q4 25
$-12.5M
$18.9M
Q3 25
$-6.1M
$8.5M
Q2 25
$-27.6M
$7.3M
Q1 25
$-19.6M
$-4.9M
Q4 24
$-12.9M
$21.1M
Q3 24
$-20.1M
$529.0K
Q2 24
$-21.8M
$3.6M
Free Cash Flow
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
$18.8M
Q3 25
$8.5M
Q2 25
Q1 25
$-4.9M
Q4 24
$21.0M
Q3 24
$519.0K
Q2 24
$3.5M
FCF Margin
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
69.5%
Q3 25
34.8%
Q2 25
Q1 25
-21.1%
Q4 24
45.2%
Q3 24
2.2%
Q2 24
15.6%
Capex Intensity
FBIO
FBIO
WHG
WHG
Q1 26
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
0.0%
0.0%
Q2 24
0.1%
Cash Conversion
FBIO
FBIO
WHG
WHG
Q1 26
-3.28×
Q4 25
10.29×
Q3 25
-1.04×
2.29×
Q2 25
-1.78×
7.08×
Q1 25
-10.25×
Q4 24
5.69×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIO
FBIO

Segment breakdown not available.

WHG
WHG

Asset-based$19.3M77%
Trust fees$5.3M21%

Related Comparisons